TABLE 1.
Clinical characteristics of subjects in validation study.
| Characteristic | Controls | CAD patients | P value |
| Demographics | |||
| Male/Female | 17/13 | 22/8 | 0.2789 |
| Age (year) | 55.27 ± 9.03 | 59.80 ± 9.26 | 0.0598 |
| Risk factors | |||
| History of HP (yes/no) | 9/21 | 20/10 | 0.0092 |
| History of DM (yes/no) | 1/29 | 8/22 | 0.0257 |
| Clinical parameters | |||
| TC (mmol/L) | 4.25 ± 0.72 | 4.53 ± 1.45 | 0.3429 |
| TG (mmol/L) | 1.14 ± 0.39 | 1.89 ± 1.43 | <0.001 |
| LDL-C (mmol/L) | 2.60 ± 0.60 | 2.80 ± 1.08 | 0.3701 |
| HDL-C (mmol/L) | 1.41 ± 0.34 | 1.30 ± 0.47 | 0.2964 |
| FPG (mmol/L) | 5.48 (5.03, 5.73) | 5.69 (5.18, 6.90) | 0.0740 |
| WBC (× 109) | 5.84 ± 1.33 | 6.33 ± 1.77 | 0.2290 |
| Monocyte (× 109) | 0.43 ± 0.11 | 0.58 ± 0.21 | <0.001 |
| Neutrophil (× 109) | 3.31 ± 1.03 | 3.97 ± 1.28 | 0.0315 |
| Lymphocyte (× 109) | 1.93 ± 0.51 | 1.60 ± 0.61 | 0.0250 |
| LMR (ratio) | 4.68 ± 1.17 | 2.98 ± 1.21 | <0.001 |
| NMR (ratio) | 7.70 (6.13, 8.85) | 6.48 (5.53, 8.90) | 0.1973 |
| NLR (ratio) | 1.68 (1.30, 2.05) | 2.58 (1.94, 3.20) | <0.001 |
Data were showed as mean ± SD, median (25 percentiles, 75 percentiles). HP, hypertension; DM, diabetes mellitus; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FPG, fasting plasma glucose; WBC, white blood cell; LMR, lymphocyte to monocyte ratio; NMR, neutrophil to monocyte ratio; NLR, neutrophil to lymphocyte ratio. Entries in bold font indicate statistically significant (P < 0.05).